These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 21351663
1. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system]. Scudla V, Herman M, Minarík J, Pika T, Hrbek J, Bacovský J, Heinzová V. Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663 [Abstract] [Full Text] [Related]
2. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma. Scudla V, Petrova P, Minarik J, Pika T, Bacovsky J. Neoplasma; 2011 Jan; 58(6):499-506. PubMed ID: 21895403 [Abstract] [Full Text] [Related]
3. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems. Fechtner K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA. Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941 [Abstract] [Full Text] [Related]
4. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma]. Ščudla V, Petrová P, Pika T, Lochman P, Minařík J, Bačovský J, Srovnalík K. Cas Lek Cesk; 2015 Oct; 154(4):181-8. PubMed ID: 26357861 [Abstract] [Full Text] [Related]
5. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma]. Scudla V, Budíková M, Petrová P, Minarík J, Pika T, Bacovský J, Adamová D, Langová K, Ceská myelomová skupina. Klin Onkol; 2010 Oct; 23(3):171-81. PubMed ID: 20608327 [Abstract] [Full Text] [Related]
6. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Dutoit JC, Vanderkerken MA, Verstraete KL. Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124 [Abstract] [Full Text] [Related]
12. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma]. Scudla V, Petrová P, Minarík J, Pika T, Budíková M, Bacovský J, Repovský S. Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472 [Abstract] [Full Text] [Related]
13. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Durie BG. Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405 [Abstract] [Full Text] [Related]
15. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M. Cancer; 2002 Sep 15; 95(6):1334-45. PubMed ID: 12216103 [Abstract] [Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important. Berenson JR, Yellin O. Clin Lymphoma Myeloma; 2009 Aug 15; 9(4):311-5. PubMed ID: 19717382 [Abstract] [Full Text] [Related]